AIP and metabolic syndrome: The prevalence of MetS and the percentage of men significantly increased with higher AIP levels, with MetS affecting 39.88% of the population in T3 and only 0.81% in T1, and the proportion of men increased to 49.69% in T3 from 9.04% in T1.